RAJKUMAR VENKATRAMANI to Response Evaluation Criteria in Solid Tumors
This is a "connection" page, showing publications RAJKUMAR VENKATRAMANI has written about Response Evaluation Criteria in Solid Tumors.
Connection Strength
0.049
-
Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study. Lancet Oncol. 2021 09; 22(9):1312-1321.
Score: 0.049